Page last updated: 2024-09-04

cyc 202 and Experimental Lung Inflammation

cyc 202 has been researched along with Experimental Lung Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blok, DC; Duitman, J; Hoogendijk, AJ; Roelofs, JJ; van der Poll, T; van Lieshout, MH; Wieland, CW	1

Other Studies

1 other study(ies) available for cyc 202 and Experimental Lung Inflammation

Article	Year
R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae. Molecular medicine (Cambridge, Mass.), 2012, Sep-25, Volume: 18 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cell Line; Chemokines; Cyclin-Dependent Kinases; Female; Humans; Inflammation Mediators; Leukocyte Count; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; Purines; Roscovitine; Streptococcus pneumoniae; Teichoic Acids	2012

Article

Year

R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae.

Molecular medicine (Cambridge, Mass.), 2012, Sep-25, Volume: 18

Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cell Line; Chemokines; Cyclin-Dependent Kinases; Female; Humans; Inflammation Mediators; Leukocyte Count; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; Purines; Roscovitine; Streptococcus pneumoniae; Teichoic Acids

2012